Clearbridge Health Limited

Equities

1H3

SG1EB6000000

Healthcare Facilities & Services

Market Closed - Singapore S.E. Other stock markets 04:21:54 2024-05-09 EDT			5-day change	1st Jan Change
0.01 ^SGD	0.00%		0.00%	-37.50%

04-29	Clearbridge Health Awards Shares Under Performance Share Plan	MT
02-29	Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT Lunadorii Utama Indonesia acquired SAM Laboratory Private Limited from Clearbridge Health Limited for SGD 8.6 million.

October 06, 2022

PT Lunadorii Utama Indonesia acquired SAM Laboratory Private Limited from Clearbridge Health Limited (Catalist:1H3) for SGD 8.6 million on October 7, 2022.

PT Lunadorii Utama Indonesia completed the acquisition of SAM Laboratory Private Limited from Clearbridge Health Limited (Catalist:1H3) on October 7, 2022.

Latest news about Clearbridge Health Limited

Clearbridge Health Awards Shares Under Performance Share Plan	04-29	MT
Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Singapore Shares Fall at Market Close; ValueMax Shares Climb 11% as H2 2023 Profit Surges 44%	02-21	MT
Clearbridge Health Cuts Stake in Singapore Institute of Advanced Medicine; Shares Rise 8%	02-21	MT
Clearbridge Health's Operations Chief to Step Down by Month-End	02-14	MT
Clearbridge Health Limited Announces Resignation of Liau Yen San, Jonathan as Chief Operating Officer	02-14	CI
Clearbridge Health Warns of Lower 2023 Revenue from COVID-19 Test Kits, Medical Services	02-11	MT
Clearbridge Health Receives Full Amount of Outstanding Debt from Biolidics	11-30	MT
Clearbridge Health Limited Announces Second Partial Settlement Deed	11-30	CI
Singapore Stocks End Week in Red; Noel Gifts Zooms 38% as Collective Sale of 50 Playfair Road Singapore Closes	11-24	MT
Clearbridge Health Unit, Biolidics Sign Deal for Partial Debt Settlement	11-24	MT
Clearbridge Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Clearbridge Health to Dispose of Over 10% Stake in Biolidics	23-07-24	MT
Clearbridge Health Limited Announces Board Changes	23-06-28	CI
Clearbridge Health Issues Shares Under Performance Share Plan	23-05-17	MT
Clearbridge Health Limited Announces Retirement of Tan Soon Liang (Chen Shunliang) as Independent Director	23-05-12	CI
Clearbridge Health Trims Losses in July-December 2022	23-05-08	MT
Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-07	CI
Clearbridge Health Gets More Time from ACRA to Hold AGM, File Annual Returns	23-04-07	MT
Biolidics Issues 37.5 Million Shares as Partial Consideration for Biomedics Acquisition	23-03-21	MT
Biolidics Gets Regulatory Nod to List Consideration Shares for Biomedics Acquisition; Shares Surge 7%	23-03-17	MT
Clearbridge Health Unit Offloads More Shares in Biolidics	22-11-16	MT
Clearbridge Health Unit Offloads Additional Stake in Biolidics; Shares Drop 5%	22-11-14	MT
Clearbridge Health Unit Offloads Additional 10% Stake in Biolidics via Open Market Transactions; Shares Drop 5%	22-10-28	MT
Clearbridge Health Unit Offloads 4% Stake in Biolidics via Open Market Transactions	22-10-27	MT

Chart Clearbridge Health Limited

Duration

Period

More charts

Company Profile

Clearbridge Health Limited is a Singapore-based investment holding company. The Company is an integrated healthcare group with primary healthcare and healthcare systems. Its segments include healthcare systems, medical clinics/centers, and strategic medical technology investments. The Companyâs healthcare system service delivery, health workforce, health information systems, access to essential medicines, and financing. The medical services include general medical services and specialist services. The general medical services include general health services, imaging services, and vaccinations. The specialist services include aesthetics services and dental and orthodontics services. The Companyâs strategic medical technology investments include Biolidics Limited (Biolidics) which owns advanced fully automated circulating tumor cell enrichment technology and is developing complete liquid biopsies solutions for clinical use.

Sector

Healthcare Facilities & Services

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CLEARBRIDGE HEALTH LIMITED	-37.50%	4.58M
HCA HEALTHCARE, INC.	+20.68%	85.55B
CVS HEALTH CORPORATION	-29.31%	70.07B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.65%	29.06B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.63%	17.51B
FRESENIUS SE & CO. KGAA	+2.14%	17.39B
QUEST DIAGNOSTICS INCORPORATED	+0.39%	15.38B
REDE D'OR SÃO LUIZ S.A.	+6.47%	13.4B
NATERA, INC.	+68.09%	12.87B
FRESENIUS MEDICAL CARE AG	+6.43%	12.77B

Other Healthcare Facilities & Services